Skip to content

Latest

Dermira gets FDA approval for Qbrexza cloth

Dermira gets FDA approval for Qbrexza cloth

Dermira announced that the U.S. Food and Drug Administration (FDA) has approved Qbrexza (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older.

Novartis seeks approval to spinoff Alcon eye care biz

Novartis seeks approval to spinoff Alcon eye care biz

Novartis today announced its intention to spinoff Alcon, its eye care division, into a separately-traded standalone company. The planned spinoff would enable Novartis and Alcon to focus fully on their respective growth strategies.

gel-e expands its OTC label

gel-e expands its OTC label

gel-e Inc., announces the 510(k) clearance of gel-e FLEX by the U.S. Food and Drug Administration (FDA) for the over-the-counter (O-T-C) use of its first flowable hemostat.

Amazon to acquire PillPack

Amazon to acquire PillPack

Amazon and PillPack today announced that they have entered into a definitive merger agreement under which Amazon will acquire PillPack. PillPack is a pharmacy said to be designed to provide the best possible customer experience in the U.S. for people who take multiple daily prescriptions.

Avella to distribute Braftovi and Mektovi

Avella to distribute Braftovi and Mektovi

Avella has announced that it will distribute Braftovi (encorafenib and Mektovi (binimetinib), a combination therapy recently FDA approved for patients for the treatment of patients with unresectable or metastatic melanoma.

Kline report looks at new beauty retail trends

Kline report looks at new beauty retail trends

Faced with the ever-increasing consumer demand for engaging experiences, the beauty retailing landscape is forced to undergo revolutionary changes. Retailers and beauty brands are adapting to these changes by offering new compelling shopping experiences and utilizing technology online and offline.